INFERTILITY/ART/IVF

FRIDAY, DECEMBER 2

08:30-10:00 THE FUTURE OF IVF I HALL A
Capsule
Chairperson Zion Ben Rafael, Israel
Joyce Harper, UK
08:30-09:00

08:30
08:40
08:50

Debate: Preparation: Should we be using expanded genetic screening in all patients?

Yes: Rita  Vassena, Spain must be on Friday
No:
Discussion

09:00-09:30

09:00
09:10
09:20

Debate: Stimulation: We should not use more than 150 units in most patients

Pro: Frank Broekmans, Netherlands
Con: Norbert Gleicher, USA
Discussion

09:30-10:00

09:30
09:40
09:50

Debate: Automation in IVF

Automation in embryo culture: Laura Rienzi, Italy
Automation in embryo freezing: Amir Arav, Israel
Discussion

 

10:00-10:20 Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 THE FUTURE OF IVF II HALL A
Capsule Laura Rienzi, Italy
Frank Broekmans, Netherlands
Chairperson
10:20-10:40 Why the PGT-A hypothesis for biological reasons, simply, cannot work
Norbert Gleicher, USA
10:40-11:15

10:40
10:50
11:00

HFEA recently downgraded PGT-A from “Amber” to “Red”, suggesting it has no proof. Are we all in agreement?Debate: PGT-a – More Harm than good?

No:
Yes:
Discussion

11:15-11:50

11:15
11:25
11:35

Debate: Standard IVF vs Add-on IVF – Futile expense? What if the patient is willing to pay for add-ons?

Pro: 
Con: Joyce Harper, UK
Discussion

 

11:50-12:10 Break

 

12:10-13:40 INDUSTRY SUPPORTED SESSION HALL A

 

13:40-14:30  Lunch break,  poster viewing and visit the exhibition Exhibition Area

 

14:30-16:30 SURGICAL TREATMENT HALL A
Capsule
Chairperson Joop Laven, Netherlands
14:30-14:55 Update on Müllerian duct anomalies: Modern surgical approaches
Sara Brucker, Germany
14:55-15:40

14:55
15:10
15:25

Debate: Cesarean scar defect: When to correct, by which method?

Pro hysteroscopy: Sylvia Mechsner, Germany
Pro laparoscopy:  Olivier Donnez, Belgium
Discussion

15:25-15:50 End of endometrial scratching?
Ben Mol, Australia
15:50-16:15 Fibroids must be treated prior to IVF – Con
Michelle Nisolle, Belgium 
16:15-16:30 Discussion

 

16:30-16:50  Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

16:50-18:20 ISMAAR SESSION HALL A
Capsule
Chairperson Geeta Nargund, UK
16:50-17:05 Natural and mild IVF – When and how to do it
Geeta Nargund, UK
17:05-17:20 The microbiome does it really matter to ART
Joop Laven, Netherlands
17:20-17:50

17:20
17:30
17:40

Debate: Duo-stim advantages and disadvantages 

Pro: Filippo Maria Ubaldi, Italy
Con: Bart Fauser, Netherlands
Discussion

17:50-18:20

17:50
18:00
18:10

Debate: Freeze only strategy for all?

Con: Ben Mol, Australia
Pro:
Discussion

 

SATURDAY, DECEMBER 3

08:30-10:00 PCOS HALL A
Capsule The definition of PCO/PCOS has changed several times during the last 4 decades. Should we change it again?  Despite our better understanding, the treatment remains a challenge
Chairpersons Bart Fauser, Netherlands
Ben Mol, Australia
08:30-08:55 PCOS: A Brain Disease?
Joop Laven, Netherlands
08:55-09:20 Defining the polycystic ovary: AMH or ultrasound?
Antonio La Marca, Italy
09:20-09:40 Does Cochrane reviews show any role for metformin in the management of PCOS?
Thomas Tang, UK
09:40-10:00 The hypo-androgenic PCOS-like phenotype at advanced ages, one of the most frequent causes of repeat IVF failure
Norbert Gleicher, USA

 

10:00-10:20  Coffee break,  poster viewing and visit the exhibition Exhibition Area

 

10:20-11:50 ADD-ONS LABORATORIES AND CLINICAL PROCEDURES HALL A
Chairpersons Laura Rienzi, Italy
Zion Ben Rafael, Israel
Bart Fauser, Netherlands
Discussants Rita Vassena, Spain
Catherine Racowsky, France
Norbert Gleicher, USA
Antonio La Marca, Italy
Joop Laven, Netherlands
Lab procedures
  • Perfect timings in the embryology lab: When to denude, when to fertilize, when to culture?
  • One or several culture media- which?
  • Noninvasive embryo selection
  • Genetic testing for donors.
Clinical procedures
  • RIF is there a valid definition?
  • Fresh versus frozen what to prepare ?
  • Optimal luteal support
  • Aromatase inhibitors

 

11:50-12:00 Break

 

12:00-13:30 ENDOMETRIOSIS ADENOMYOSIS HALL A
Capsule The concept that uterine adenomyosis and pelvic endometriosis as well as endometriotic lesions at distant sites of the body share a common pathophysiology with endometriosis was promoted almost a decade ago. What is the current thinking?
Chairpersons Zion Ben Rafael, Israel
Olivier Donnez, Belgium
Adenomyosis and deep endometriosis: Two linked diseases?
Jacques Donnez, Belgium
12:00-12:20 Adenomyosis and deep endometriosis: Two linked diseases?
Jacques Donnez, Belgium
12:20-12:40 Uterine adenomyosis: Can surgery help?
12:40-13:10

12:40
12:50
13:00

Debate: The endometrioma and the ovarian reserve: The challenge of the surgeon

To operate first:
ART before operation: Edgardo Somigliana, Italy
Discussion

13:10-13:30 Medical targets in endometriosis
Ludwig Kiesel, Germany

 

13:30-14:20 Lunch break,  poster viewing and visit the exhibition Exhibition Area

 

14:20-15:50 HORMONAL ASPECTS OF HUMAN FERTILITY HALL A
Capsule
Chairperson Edgardo Somigliana, Italy
14:20-14:40 The luteal phase in ART: are we gaining ground?
14:40-15:05 Women’s biological clock, the molecular mechanisms
Eva Hoffmann, Denmark
15:05-15:25 40 years of experience with the German IVF registry
Klaus Bühler, Germany
15:25-15:50 Does social egg freezing increase woman’s emancipation?
Guido Pennings, Belgium

 

15:50-16:00 Break

 

16:00-17:00  SURGICAL ASPECTS OF FERTILITY HALL A
Capsule
Chairperson Ludwig Kiesel, Germany
16:00-16:20 40 years of experience with the German IVF registry
Klaus Bühler, Germany
16:20-16:40 Recurrent pregnancy loss (RPL)- what are the solutions
16:40-17:00 Fertility surgery, myoma